Inactivation of Rbx1 E3 ligase suppresses KrasG12D‐driven lung tumorigenesis

Inactivation of Rbx1 E3 ligase suppresses KrasG12D‐driven lung tumorigenesis

Bibliographic Details
Main Authors:	Yanan Li, Di Wu, Haomin Li, Yi Sun
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	MedComm
Online Access:	https://doi.org/10.1002/mco2.332

Similar Items

Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation
by: Qiang Zhang, et al.
Published: (2016-11-01)

p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.
by: Özgün Le Roux, et al.
Published: (2024-01-01)

Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization
by: Mingjia Tan, et al.
Published: (2015-01-01)

CBX4 deletion promotes tumorigenesis under KrasG12D background by inducing genomic instability
by: Fangzhen Chen, et al.
Published: (2023-09-01)

Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice
by: Gaurav Kumar, et al.
Published: (2021-06-01)

Correction: Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
Published: (2009-08-01)

Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
by: Shaima’a Hamarsheh, et al.
Published: (2020-04-01)

Differential Cell Susceptibilities to KrasG12D in the Setting of Obstructive Chronic PancreatitisSummary
by: Chanjuan Shi, et al.
Published: (2019-01-01)

Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors
by: Patricia Santofimia-Castaño, et al.
Published: (2024-02-01)

The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness
by: Di Wu, et al.
Published: (2022-05-01)

Covalent inhibitor targets KRasG12C: A new paradigm for drugging the undruggable and challenges ahead
by: Hui-yu Li, et al.
Published: (2023-03-01)

Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors
by: Lisa Goebel, et al.
Published: (2023-03-01)

Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice
by: Mu Xu, et al.
Published: (2018-08-01)

SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets
by: Xiufang Xiong, et al.
Published: (2018-12-01)

Conditional knockout of N-WASP enhanced the formation of keratinizing squamous cell carcinoma induced by KRasG12D
by: Kalailingam, Pazhanichamy, et al.
Published: (2024)

KrasG12D induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells
by: Angela J. Mathison, et al.
Published: (2021-10-01)

Constitutively Active Akt1 Cooperates with KRasG12D to Accelerate In Vivo Pancreatic Tumor Onset and Progression
by: Toya M. Albury, et al.
Published: (2015-02-01)

Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice.
by: Hui-Hua Chang, et al.
Published: (2017-01-01)

Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
by: Lu Huang, et al.
Published: (2015-01-01)

High-throughput, single-particle tracking reveals nested membrane domains that dictate KRasG12D diffusion and trafficking
by: Yerim Lee, et al.
Published: (2019-11-01)

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic TumorigenesisSummary
by: Nicolas Chuvin, et al.
Published: (2017-09-01)

The KRASG12C inhibitors in lung cancer therapy
by: Maciej Jędrak, et al.
Published: (2023-09-01)

Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models
by: Daniel J. Sisler, et al.
Published: (2023-02-01)

Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras–PDAC model
by: Qiang Zhang, et al.
Published: (2020-06-01)

Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.
by: Minzhao Huang, et al.
Published: (2014-01-01)

Sotorasib in KRASG12C mutated lung cancer: Can we rule out cracking KRAS led to worse overall survival?
by: Timothée Olivier, et al.
Published: (2023-02-01)

Inhibition of Pancreatic Intraepithelial Neoplasia Progression to Carcinoma by Nitric Oxide-Releasing Aspirin in p48Cre/+-LSL-KrasG12D/+ Mice
by: Chinthalapally V. Rao, et al.
Published: (2012-09-01)

Deciphering the molecular interplay and tumorigenesis in hepatocellular carcinoma through insights into FBXL6 and KRASG12D
by: Qiang Cai, et al.
Published: (2024-02-01)

Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice
by: Yaroslav Teper, et al.
Published: (2023-09-01)

Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice
by: Hao-Jun Xiong, et al.
Published: (2023-12-01)

Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
by: Irati Macaya, et al.
Published: (2023-10-01)

Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma
by: Fernando C. Baltanás, et al.
Published: (2023-09-01)

Breaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesis
by: Herwig P. Moll, et al.
Published: (2018-11-01)

Chemically modified neoantigen-based immunotherapy for targeting KRASG12C-driven tumors
by: Abdel Mouti, M, et al.
Published: (2023)

AGO2 in overexpression exhibits oncogenic functions KrasG̳1̳2̳D̳ -associated mouse tumor models
by: Thai, Kevin K. (Kevin Kinh)
Published: (2018)

The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
by: Karys M Hildebrand, et al.
Published: (2021-01-01)

Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
by: Sharmila Shankar, et al.
Published: (2011-01-01)

RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival
by: Sun Yi, et al.
Published: (2009-08-01)

Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis.
by: Phuoc T Tran, et al.
Published: (2012-01-01)

Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model
by: Concetta Panebianco, et al.
Published: (2023-04-01)